Tuesday, May 27, 2014

What Role Does MSG Play in Obesity and Fatty Liver Disease?


Vicki Cohn
May 27, 2014

The commonly used food additive monosodium glutamate (MSG) has been linked to obesity and disorders associated with the metabolic syndrome including progressive liver disease. A new study that identifies MSG as a critical factor in the initiation of obesity and shows that a restrictive diet cannot counteract this effect but can slow the progression of related liver disease is published in Journal of Medicinal Food, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The paper is available on the Journal of Medicinal Food website.


No comments:

Post a Comment